Cormorant-capital
Cormorant is a venture firm that provides investment management advisory services to the real estate industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Cormorant-capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
5,406,316Website Global Rank
1,711Website Monthly Traffic
Twitter Followers
Description
Cormorant is a venture firm that provides investment management advisory services to the real estate industry.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2020 | VectivBio | Equity | 110M |
| 7/2019 | Revolution Medicines | Series C | 100M |
| 9/2017 | BridgeBio Pharma | Series C | 135M |
| 11/2020 | Prometheus Biosciences | Equity | 130M |
| 4/2018 | CMAB BioPharm | Series B | 0 |
| 2/2021 | Shoreline Biosciences | Series A | 0 |
| 1/2019 | Cabaletta Bio | Series B | 0 |
| 12/2021 | Freenome | Series D | 300M |
| 4/2019 | Satsuma Pharmaceuticals | Series B | 0 |
| 1/2019 | BridgeBio Pharma | Equity | 299.2M |
| 12/2021 | Freenome | Series D | 0 |
| 2/2021 | Shoreline Biosciences | Series A | 0 |
| 11/2020 | Prometheus Biosciences | Private Equity Round | 0 |
| 10/2020 | VectivBio | Venture Round | 0 |
| 7/2019 | Revolution Medicines | Series C | 0 |
| 4/2019 | Satsuma Pharmaceuticals | Series B | 0 |
| 1/2019 | BridgeBio Pharma | Series D | 0 |
| 1/2019 | Cabaletta Bio | Series B | 0 |
| 4/2018 | CMAB BioPharm | Series B | 0 |
| 9/2017 | BridgeBio Pharma | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
